Dissecting the genomic complexity underlying medulloblastoma

Nature

Volumn 488, Issue 7409, 2012, Pages 100-105

  Jones, David T W ^a   Jäger, Natalie ^a   Kool, Marcel ^a   Zichner, Thomas ^b   Hutter, Barbara ^a   Sultan, Marc ^c   Cho, Yoon Jae ^d   Pugh, Trevor J ^e   Hovestadt, Volker ^a   Stütz, Adrian M ^b   Rausch, Tobias ^b   Warnatz, Hans Jörg ^c   Ryzhova, Marina ^f   Bender, Sebastian ^a   Sturm, Dominik ^a   Pleier, Sabrina ^a   Cin, Huriye ^a   Pfaff, Elke ^a   Sieber, Laura ^a   Wittmann, Andrea ^a   Remke, Marc ^a   Witt, Hendrik ^a,g   Hutter, Sonja ^a   Tzaridis, Theophilos ^a   Weischenfeldt, Joachim ^b   Raeder, Benjamin ^b   Avci, Meryem ^c   Amstislavskiy, Vyacheslav ^c   Zapatka, Marc ^a   Weber, Ursula D ^a   Wang, Qi ^a   Lasitschka, Bärbel ^a   Bartholomae, Cynthia C ^a   Schmidt, Manfred ^a   von Kalle, Christof ^a   Ast, Volker ^a   Lawerenz, Chris ^a   Eils, Jürgen ^a   Kabbe, Rolf ^a   Benes, Vladimir ^b   van Sluis, Peter ^h   Koster, Jan ^h   Volckmann, Richard ^h   Shih, David ⁱ   Betts, Matthew J ^j   Russell, Robert B ^j   Coco, Simona ^k   Tonini, Gian Paolo ^k   Schüller, Ulrich ^l   Hans, Volkmar ^m   Graf, Norbert ⁿ   Kim, Yoo Jin ⁿ   Monoranu, Camelia ^o   Roggendorf, Wolfgang ^o   Unterberg, Andreas ^g   Herold Mende, Christel ^g   Milde, Till ^a,g   Kulozik, Andreas E ^g   von Deimling, Andreas ^a,j   Witt, Olaf ^a,g   Maass, Eberhard ^p   Rössler, Jochen ^q   Ebinger, Martin ^r   Schuhmann, Martin U ^r   Frühwald, Michael C ^s   Hasselblatt, Martin ^t   Jabado, Nada ^u   Rutkowski, Stefan ^v   von Bueren, André O ^v   Williamson, Dan ^w   Clifford, Steven C ^w   Mc Cabe, Martin G ^x,y   Collins, V Peter ^y   Wolf, Stephan ^a   Wiemann, Stefan ^a   Lehrach, Hans ^c   Brors, Benedikt ^a   Scheurlen, Wolfram ^z   Felsberg, Jörg ^aa   Reifenberger, Guido ^aa   Northcott, Paul A ⁱ   Taylor, Michael D ⁱ   Meyerson, Matthew ^e,ab   Pomeroy, Scott L ^e,ac   Yaspo, Marie Laure ^c   Korbel, Jan O ^b   Korshunov, Andrey ^a,j   Eils, Roland ^a,j   Pfister, Stefan M ^a,g   Lichter, Peter ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^d STANFORD UNIVERSITY   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f BURDENKO NEUROSURGICAL INSTITUTE   (Russian Federation)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h UNIVERSITY OF AMSTERDAM   (Netherlands)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j UNIVERSITY OF HEIDELBERG   (Germany)

^k UNIVERSITY OF GENOA   (Italy)

^l UNIVERSITY OF MUNICH   (Germany)

^m EVANGELISCHES KRANKENHAUS   (Germany)

ⁿ SAARLAND UNIVERSITY   (Germany)

^o UNIVERSITY OF WÜRZBURG   (Germany)

^p OLGAHOSPITAL   (Germany)

^q UNIVERSITY OF FREIBURG   (Germany)

^r UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^s Children's Hospital Augsburg   (Germany)

^t UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^u RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^v UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^w NEWCASTLE UNIVERSITY   (United Kingdom)

^x UNIVERSITY OF MANCHESTER   (United Kingdom)

^y UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^z Cnopf'Sche Kinderklinik Nü Rnberg Children's Hospital   (Germany)

^aa HEINRICH HEINE UNIVERSITY   (Germany)

^ab DANA FARBER CANCER INSTITUTE   (United States)

^ac BOSTON CHILDREN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRG1 PROTEIN; CTDNEP1 PROTEIN; CTNNB1 PROTEIN; DDX3X PROTEIN; KDM6A PROTEIN; MLL2 PROTEIN; PROTEIN PATCHED 1; TBR1 PROTEIN; UNCLASSIFIED DRUG; BETA CATENIN; CELL SURFACE RECEPTOR; CTDNEP1 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; DDX3X PROTEIN, HUMAN; DEAD BOX PROTEIN; DNA BINDING PROTEIN; EOMES PROTEIN, HUMAN; HELICASE; HISTONE DEMETHYLASE; MLL2 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PATCHED RECEPTORS; PHOSPHOPROTEIN PHOSPHATASE; SHH PROTEIN, HUMAN; SMARCA4 PROTEIN, HUMAN; SONIC HEDGEHOG PROTEIN; T BOX TRANSCRIPTION FACTOR; TBR1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN; UTX PROTEIN, HUMAN; WNT PROTEIN;

BRAIN; CANCER; CHILD HEALTH; DISEASE INCIDENCE; DISEASE TREATMENT; GENE EXPRESSION; GENETIC ANALYSIS; MEDICINE; MENTAL HEALTH; MOLECULAR ANALYSIS; MORTALITY; MUTATION; PHYSIOLOGY; PROTEIN; QUALITY OF LIFE; SIGNALING; SURVIVORSHIP; TUMOR;

ARTICLE; CANCER GRADING; CHROMATIN; DNA SEQUENCE; EXOME; FUSION GENE; GENE IDENTIFICATION; GENE MUTATION; GENOME; HEDGEHOG; HUMAN; MEDULLOBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RNA SEQUENCE; TETRAPLOIDY; TUMOR GENE; AGING; AMINO ACID SEQUENCE; CELL TRANSFORMATION; CEREBELLUM TUMOR; CHILD; CLASSIFICATION; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN CHROMOSOME; HUMAN GENOME; METABOLISM; METHYLATION; MUTATION; MUTATION RATE; PATHOLOGY; POLYPLOIDY; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

ERINACEIDAE;

AGING; AMINO ACID SEQUENCE; BETA CATENIN; CELL TRANSFORMATION, NEOPLASTIC; CEREBELLAR NEOPLASMS; CHILD; CHROMATIN; CHROMOSOMES, HUMAN; DEAD-BOX RNA HELICASES; DNA HELICASES; DNA-BINDING PROTEINS; GENOME, HUMAN; GENOMICS; HEDGEHOG PROTEINS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTONE DEMETHYLASES; HUMANS; MEDULLOBLASTOMA; METHYLATION; MUTATION; MUTATION RATE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PHOSPHOPROTEIN PHOSPHATASES; POLYPLOIDY; RECEPTORS, CELL SURFACE; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 84864419974     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature11284     Document Type: Article

References (25)

1. Louis, D. N. et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114, 97-109 (2007).
2. Kool, M. et al. Molecularsubgroups of medulloblastoma: an international metaanalysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol. 123, 473-484 (2012).
3. Taylor, M. D. et al. Molecularsubgroups of medulloblastoma: the current consensus. Acta Neuropathol. 123, 465-472 (2012).
4. Clifford, S. C. et al. Wnt/Wingless pathway activation and chromosome 6 loss characterise a distinct molecular sub-group of medulloblastomas associated with a favourable prognosis. Cell Cycle 5, 2666-2670 (2006).
5. Northcott, P. A. et al. Medulloblastoma comprises four distinct molecular variants. J. Clin. Oncol. 29, 1408-1414 (2011).
6. Rausch, T. et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148, 59-71 (2012).
7. Rello-Varona, S. et al. Preferential killing of tetraploid tumor cells by targeting the mitotic kinesin Eg5. Cell Cycle 8, 1030-1035 (2009).
8. Vitale, I. et al. Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway. PLoS ONE 2, e1337 (2007).
9. Parsons, D. W. et al. The genetic landscape of the childhood cancer medulloblastoma. Science 331, 435-439 (2011).
10. Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157-1160 (2011).
11. Wang, L. et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med. 365, 2497-2506 (2011).
12. Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226-231 (2012).
13. Kool, M. et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS ONE 3, e3088 (2008).
14. Pfister, S. et al. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J. Clin. Oncol. 27, 1627-1636 (2009).
15. Thompson, M. C. et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J. Clin. Oncol. 24, 1924-1931 (2006).
16. Pietsch, T. et al. Medulloblastomas of the desmoplastic variant carry mutations of the human homologueof Drosophila patched. Cancer Res. 57, 2085-2088(1997).
17. van Haaften, G. et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nature Genet 41, 521-523 (2009).
18. Satow, R., Kurisaki, A., Chan, T. C., Hamazaki, T.S. & Asashima, M. Dullard promotes degradation and dephosphorylation of BMP receptors and is required for neural induction. Dev. Cell 11, 763-774 (2006).
19. Han, S. et al. Nuclearenvelope phosphatase 1-regulatorysubunit 1 (formerly TMEM188) is the metazoan Spo7p ortholog and functions in the lipin activation pathway. J. Biol. Chem. 287, 3123-3137 (2012).
20. Kim, Y. et al. A conserved phosphatase cascade that regulates nuclear membrane biogenesis. Proc. Natl Acad. Sci. USA 104, 6596-6601 (2007).
21. Northcott, P. A. et al. Multiple recurrent genetic events convergeon control of histone lysine methylation in medulloblastoma. Nature Genet 41, 465-472 (2009).
22. Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27-40 (2011).
23. Gilbertson, R. J., Perry, R. H., Kelly, P. J., Pearson, A. D. J. & Lunec, J. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res. 57, 3272-3280 (1997).
24. Hevner, R. F. et al. Tbr1 regulates differentiation of the preplate and layer 6. Neuron 29, 353-366 (2001).
25. Englund, C. et al. Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex. J. Neurosci. 25, 247-251 (2005).